| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $2.23 | $2.26 | $2.51 | $3.03 | $3.54 | $0.75 | $0.60 | $0.80 |
| EPS (Diluted) | $2.23 | $2.26 | $2.51 | $3.02 | $3.53 | $0.75 | $0.60 | $0.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.7B | $18.7B | $17.7B | $16.9B | $16.9B | $16.4B | $15.7B | $12.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $0.6B | $0.6B | $0.4B | $1.3B | $0.9B | $0.2B | $0.2B |
| Total Liabilities | $23.7B | $15.9B | $15.2B | $14.5B | $14.2B | $13.7B | $13.1B | $10.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.0B | $2.8B | $2.5B | $2.4B | $2.7B | $2.8B | $2.6B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.1B | $0.2B | $0.2B |
| Investing Cash Flow | $-0.1B | $-1.0B | $-0.5B | $-1.1B | $-0.3B | $0.1B | $0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $0.8B | $0.6B | $0.0B | $0.3B | $0.6B | $-0.2B | $-0.1B |